Search

Your search keyword '"Timothy D Henry"' showing total 299 results

Search Constraints

Start Over You searched for: Author "Timothy D Henry" Remove constraint Author: "Timothy D Henry" Publisher elsevier bv Remove constraint Publisher: elsevier bv
299 results on '"Timothy D Henry"'

Search Results

2. Impact of COVID-19 on Acute Myocardial Infarction Care

4. Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure

5. Mechanical Circulatory Support in Patients With COVID-19 Presenting With Myocardial Infarction

7. Eligibility of out-of-hospital cardiac arrest patients for extracorporeal cardiopulmonary resuscitation in the United States: A geographic information system model

8. Contemporary Management of Refractory Angina

9. Management Principles for the Cardiac Catheterization Laboratory During the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Pandemic

11. Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols

12. Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19

13. Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging

14. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations

16. Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with ST-Segment Elevation Acute Myocardial Infarction

17. Cardiology Research Internship for Undergraduate Students Provides Unique Opportunity for Next Generation of Health Care Professionals

20. LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry

21. In-Hospital cardiac arrest complicating ST-elevation myocardial Infarction: Temporal trends and outcomes based on management strategy

22. Covid-19

23. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI

24. Acute Carbon Monoxide Poisoning and Cardiac Magnetic Resonance

25. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients

26. Management of Acute Myocardial Infarction During the COVID-19 Pandemic

27. Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry)

28. Cardiac Imaging in the Post-ISCHEMIA Trial Era

29. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic

30. Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest

31. Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patients

32. Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock

33. Refractory Angina

36. Adopting Best Practices in the Management of Coronary Calcification

39. Resilience in the Face of Adversity

42. Cardiogenic Shock Classification to Predict Mortality in the Cardiac Intensive Care Unit

43. Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction

44. Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age

45. Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention

46. COVID-19

47. TCT-67 Mechanical Circulatory Support in Patients With COVID-19 Presenting With Myocardial Infarction: Analysis From the North American COVID-19 Myocardial Infarction Registry

48. TCT-34 Hemoglobin Drop in the Absence of Overt Bleeding After Percutaneous Coronary Intervention is Associated With In-Hospital Mortality

Catalog

Books, media, physical & digital resources